“…Prospective studies in mice shed light on this apparent paradox and clearly demonstrated that disabling Th1 immune responses by in vivo neutralization of IFN-γ or through the use of IFN-γ −/− hosts resulted in a strong Th2-based alloimmune response and an exacerbation, not mitigation, of immune rejection of corneal allografts [34, 45–50]. Moreover, mouse studies incorporating well-defined allergens revealed that Th2-based allergic diseases did indeed increase the incidence and tempo of corneal allograft rejection [45, 46, 48–50]. By employing a murine model of allergic asthma it was possible to determine that allergic diseases, even those which occur in organs distant from the eye, have a profound adverse effect on corneal allograft survival [48].…”